tirzepatide china approval Lilly's Weight-Loss Drug Approved in Amid Race With Novo China Clears Eli Lilly's Weight

Mark Swain, Hepatologist, Professor of Medicine, University of Calgary: " Having treatment options in this patient population is extremely needed because the disease affects a large population, has a high risk of severe complications like liver cirrhosis and cancer, and lacks effective treatments

PlexusDx emphasizes precision-based decision-making by combining clinical evidence with biomarker and genetic context, enabling more targeted treatment selection aligned with individual physiology

doi: 10.1016/j.ijcard.2011.09.039 260 McGuireDKShihWJCosentinoFCharbonnelBCherneyDZIDagogo-JackSet al

For instance, high protein diet, Mediterranean-style diet, low carbohydrate diet, low-calorie diet, and low-fat diet are just several options [42,43]